Location History:
- Copenhagen, DK (2011 - 2015)
- Københabn Ø, DK (2015)
- Maaloev, DK (2016 - 2020)
Company Filing History:
Years Active: 2011-2020
Title: Dorte Bjerre Steensgaard: Innovator in Diabetes Treatment
Introduction
Dorte Bjerre Steensgaard is a prominent inventor based in Maaloev, Denmark. She has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of diabetes. With a total of 6 patents to her name, her work has had a substantial impact on medical therapies.
Latest Patents
One of her latest patents focuses on insulin-containing pharmaceutical compositions. This invention is aimed at treating medical conditions related to diabetes. Specifically, it provides pharmaceutical compositions that comprise a long-acting acylated derivative of a human insulin analogue. The medical use of such compositions is intended for basal insulin administration therapy. This innovative approach enhances the effectiveness of diabetes treatment.
Career Highlights
Dorte Bjerre Steensgaard is associated with Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care. Her work at Novo Nordisk has allowed her to develop groundbreaking solutions that improve the quality of life for individuals with diabetes. Her dedication to research and innovation has positioned her as a key figure in the pharmaceutical industry.
Collaborations
Throughout her career, Dorte has collaborated with notable colleagues, including Morten Schlein and Svend Havelund. These partnerships have fostered an environment of innovation and have contributed to the advancement of diabetes treatment solutions.
Conclusion
Dorte Bjerre Steensgaard's contributions to diabetes treatment through her innovative patents and work at Novo Nordisk A/S highlight her importance in the field of pharmaceutical research. Her dedication to improving medical therapies continues to inspire advancements in healthcare.